Skip to main content

Day: April 28, 2020

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results

-Enrollment ongoing in clinical trials of CTX001™ for patients with severe hemoglobinopathies--Enrollment ongoing in clinical trial of CTX110™, targeting CD19+ malignancies--Began treating patients in clinical trial of CTX120™, targeting B-cell maturation antigen (BCMA)--IND and CTA approved for CTX130™, wholly-owned allogeneic CAR-T cell therapy targeting CD70--Received $25 million milestone payment from DMD/DM1 collaboration with Vertex in April 2020-ZUG, Switzerland and CAMBRIDGE, Mass., April 28, 2020 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today reported financial results for the first quarter ended March 31, 2020.“We made substantial progress in the last quarter despite the challenges posed by COVID-19. ...

Continue reading

Precision BioSciences Announces Presentations at the American Society of Gene & Cell Therapy 23rd Annual Meeting

DURHAM, N.C., April 28, 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a life sciences company dedicated to improving life through the application of its pioneering, proprietary ARCUS® gene editing platform, today announced that the Company and its collaborators will present at the upcoming American Society of Genetic & Cell Therapy (ASGCT) Annual Meeting held virtually May 12-15, 2020.“The abstracts being presented by Precision and our collaborators this year at ASGCT underscore the differentiated capabilities of our proprietary ARCUS genome editing platform and the breadth of our emerging pipeline applying this technology in vivo,” commented Derek Jantz, Chief Scientific Officer and co-founder of Precision BioSciences. “These presentations demonstrate the specificity and versatility of ARCUS-driven genome...

Continue reading

AMG Appoints Reuben Jeffery to its Board of Directors

New independent Director will enhance diversity of expertise within AMG’s Board of DirectorsNathaniel Dalton and Niall Ferguson announce their intention not to seek re-election at 2020 Annual MeetingWEST PALM BEACH, Fla., April 28, 2020 (GLOBE NEWSWIRE) — Affiliated Managers Group, Inc. (NYSE: AMG), a global asset management company, today announced the appointment of Reuben Jeffery to its Board of Directors, effective immediately.Reuben Jeffery III served as President and Chief Executive Officer and member of the board of Rockefeller & Co. and Rockefeller Financial Services, Inc. from 2010 to 2018. He previously served seven years in the U.S. government in a variety of positions, including as Under Secretary of State for Economic, Energy and Agricultural Affairs; Chairman of the U.S. Commodity Futures Trading Commission; and...

Continue reading

Copper Lake Announces Appointment of New Director to the Board

TORONTO, April 28, 2020 (GLOBE NEWSWIRE) — Copper Lake Resources Ltd. (TSX-V: CPL, Frankfurt: W0I) (“Copper Lake” or the “Company”) is pleased to announce the appointment of Ms. Naomi Johnson, LL.B. to the Company’s Board of Directors.Ms. Johnson is a lawyer with over 12 years of experience working in the mineral industry as a global Corporate Social Responsibility executive, primarily in a community relations role both domestically and internationally.  From 2008 to 2017, Ms. Johnson worked for Barrick Gold Corporation in a number of senior roles, most recently serving as Partner and Senior Director, Community Relations.Copper Lake Chief Executive Officer Terry MacDonald commented, “I am very pleased to welcome Naomi to Copper Lake’s Board of Directors.  As an expert in CSR and community engagement best...

Continue reading

Huntington Ingalls Industries Declares Quarterly Dividend

NEWPORT NEWS, Va., April 28, 2020 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE:HII) announced today that its Board of Directors has declared a quarterly cash dividend of $1.03 per share, payable on June 12, 2020, to shareholders of record as of the close of business on May 29, 2020.Huntington Ingalls Industries is America’s largest military shipbuilding company and a provider of professional services to partners in government and industry. For more than a century, HII’s Newport News and Ingalls shipbuilding divisions in Virginia and Mississippi have built more ships in more ship classes than any other U.S. naval shipbuilder. HII’s Technical Solutions division supports national security missions around the globe with unmanned systems, defense and federal solutions, nuclear and environmental services, and fleet sustainment....

Continue reading

Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 1Q20

Lima, April 28, 2020 (GLOBE NEWSWIRE) — Lima, PERU, April 28th, 2020 – Credicorp Ltd. announces to its shareholders and the market that its 1Q20 Earnings Release Report will be released on Thursday May 07th, 2020 after market close.Credicorp’s Conference Call to discuss such results will be held on Friday May 08th, 2020 at 10:30 am EST (9:30 am Lima, Peru Time). The call will be host by: Walter Bayly, CEO, Alvaro Correa, Deputy Chief Executive Officer, Gianfranco Ferrari, Deputy Chief Executive Officer, Reynaldo Llosa, Chief Risk Officer, Cesar Rios, Chief Financial Officer and Investor Relations Team.To access the call, please dial:1 877 271 1828 within the U.S.1 334 323 9871 from outside the U.S.Participant Code: 643525The conference call will also be webcast live, to accessed please visit our website:www.credicorpnet.comAn accompanying...

Continue reading

Meritage Homes reports first quarter 2020 diluted EPS of $1.83

SCOTTSDALE, Ariz., April 28, 2020 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, reported first quarter results for the period ended March 31, 2020.Summary Operating Results (unaudited)(Dollars in thousands, except per share amounts)MANAGEMENT COMMENTS“We reported select preliminary operating results for the first quarter of 2020 on April 6, which reflected stronger-than anticipated market demand through early March, followed by significant declines through the end of the month, which have continued to deteriorate in April as the coronavirus pandemic spread across the U.S. and severely impacted the economy,” said Steven J. Hilton, chairman and chief executive officer of Meritage Homes.“Though our net earnings for the first quarter more than doubled and every key operating metric showed significant...

Continue reading

CDW Announces Move to Virtual Annual Meeting of Stockholders for 2020

LINCOLNSHIRE, Ill., April 28, 2020 (GLOBE NEWSWIRE) — CDW Corporation (Nasdaq:CDW) today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic, related governmental actions and the importance of safeguarding the health of its stockholders, coworkers and representatives, CDW will hold its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) solely by means of remote communication (i.e., a virtual-only meeting). Stockholders will not be able to attend the Annual Meeting in person.The Annual Meeting will be held on Thursday, May 21, 2020 at 7:30 a.m. CDT in a virtual format only at www.virtualshareholdermeeting.com/CDW2020. As described in the proxy materials for the Annual Meeting previously distributed, stockholders as of the close of business on March 25, 2020, the record date, are entitled...

Continue reading

Intellia Therapeutics to Present New Preclinical Data from Its CRISPR/Cas9 Programs at the 23rd Annual Meeting of the American Society of Gene and Cell Therapy

CAMBRIDGE, Mass., April 28, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, announced that five abstracts were accepted for the 23rd Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), taking place virtually from May 12-15, 2020. Abstracts are available on the ASGCT website.Intellia’s data include important updates about the company’s progress and platform development activities:Oral Presentations“Enhanced tgTCR T Cell Product Attributes Through Process Improvement of CRISPR/Cas9 Engineering”As a follow-on to data presented at Keystone Symposia’s Engineering the Genome Conference this past February, Intellia’s ASGCT presentation will focus on process improvements...

Continue reading

Westport Fuel Systems to Resume Production at Italian Operations

VANCOUVER, British Columbia, April 28, 2020 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport Fuel Systems” or the “Company”) (TSX:WPRT / Nasdaq:WPRT) today announced that production and manufacturing will fully resume at its facilities in Cherasco, Brescia, and Albinea, Italy on May 4, 2020 given the Italian Government’s decree of April 24, 2020. The Company’s Italian operations have significantly expanded measures to protect its workforce in accordance with government protocols for health and safety including social distancing requirements, personal protective equipment, cleaning protocols, and other measures to help mitigate the spread of COVID-19.“The safe and organized restart of our Italian operations is an important signal for our employees, customers, suppliers, shareholders, and the local economy,” said David M....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.